Data from Cistrome_DB also showed higher USF2 binding scores to oncogenic metabolic hubs, but these scores were minimal to none for tumor suppressor metabolic hubs in bladder cancer (Figure 5D) suggesting USF2 as key transcription factor to regulate oncogenic metabolic hubs in bladder cancer. This evidence concerns the gene USF2 and urinary bladder carcinoma.